Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia

Chaoke Bu, MD, Zhiyong Peng, MD, Min Luo, Guangchao Li, PhD, Chunfu Li, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-140648

Published: 2020

Journal Articles

A Busulfan Following Cyclophosphamide and Constant Cell Dose Protocol Improved Results in Alternative Donor Hematologic Stem Cell Transplantation in Thalassemia Major: A Result from Long-Term Large-Size Multi-Center Study

Yuelin He, MD, Hua Jiang, MD PhD, Changgang Li, MD, Yiping Zhu, MD, Xuedong Wu, MD PhD, Liu Sixi, MD PhD, Qu Yuhua, MD, Jiangyu Liao, MD, Xiaoqin Feng, Huaying Liu, MD, Zhiyong Peng, MD, Lan He, MD, Chaoke Bu, MD, Gautam Mandeen, MD, Leung Wing, MD PhD, Chunfu Li, MD

Blood (2019) 134 (Supplement_1): 970.

https://doi.org/10.1182/blood-2019-130202

Published: 2019

Journal Articles

Manufacturing Scale-up and Preclinical Development of ET-01, Autologous CD34 + Cells with the BCL11A Erythroid Enhancer Edited By CRISPR/Cas9, for Patients with β-Thalassemia Major

Riguo Fang, PhD, Pengfei Yuan, PhD, Lingling Yu, Bachelor, Huihui Yang, Master, Jie Liu, Master, Jia Shi, PhD, Yongjian Zhang, PhD, Wei Zhang, PhD, Yiding Zhao, PhD, Zhiyong Peng, MD, Chunfu Li, MD, Yun Li, MD, Dong Wei, PhD

Blood (2019) 134 (Supplement_1): 965.

https://doi.org/10.1182/blood-2019-126499

Published: 2019

Journal Articles

Complementary Transplantation with Unrelated Cord Blood Following Haploidentical Stem Cells for Juvenile Myelomonocytic Leukemia:Double-Centers Study from China

Zhiyong Peng, MD, Xiaoqin Feng, Huaying Liu, MD, Jianyun Liao, MD, Chaoke Bu, Yuelin He, MD, Jianmin Zhang, MD, Jingyu Gao, Chunfu Li, MD

Blood (2019) 134 (Supplement_1): 4181.

https://doi.org/10.1182/blood-2019-128331

Published: 2019

Journal Articles

Improvement of Survival in JMML By Induction Regimen of Decitabine + Cytarabine + Fludarabine before Hematopoietic Stem Cell Transplantation: Study of 33 Cases in Single Center

Xiaoqin Feng, Zhiyong Peng, MD, Yuelin He, MD, Chunfu Li, MD, Yongsheng Ruan, MD, Xuan Liu, Rongfang Ding, MD, Wanxia Tan

Blood (2019) 134 (Supplement_1): 4267.

https://doi.org/10.1182/blood-2019-130488

Published: 2019

Journal Articles

Complementary Transplantation Improved Results of Both Peripheral Blood Stem Cells and Unrelated Cord Blood Transplants in Thalassemia: A Multi-Center Study from China

Chunfu Li, MD, Sixi Liu, MD PhD, Yuelin He, MD, Xiaodong Wang, MD, Jianyun Liao, MD, Shan Li, MD, Xiaolin Zheng, MD, Xuedong Wu, MD PhD, Changgang Li, MD, Xiaoqin Feng, Feiqiu Wen, MD PhD, Huaying Liu, MD, Xiaohui Zhou, MD, Zhiyong Peng, MD, Lan He, MD, Chaoke Bu, MD, Leung Wing, MD PhD

Blood (2019) 134 (Supplement_1): 4617.

https://doi.org/10.1182/blood-2019-129697

Published: 2019

Journal Articles

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

Jianyun Liao, MD, Xiaoting Liu, Yuelin He, MD, Zhiyong Peng, MD, Huaying Liu, MD, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 2344.

https://doi.org/10.1182/blood-2018-99-118142

Published: 2018

Journal Articles

A Retrospective Analysis of Transplantation Related Mortality in 515 Cases of Children β-Thalassemia Major

Yuhua Xiao, Chunfu Li, MD, Yuelin He, Xuedong Wu, MD, Zhiyong Peng, MD, Yuqiong Ren, Yongsheng Ruan, MD, Xiaoqin Feng, PhD

Blood (2018) 132 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2018-99-118739

Published: 2018

Journal Articles

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Zhiyong Peng, MD, Xiaoqin Feng, PhD, Huaying Liu, MD, Yuelin He, Jianyun Liao, MD, Xiaoting Liu, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 5778.

https://doi.org/10.1182/blood-2018-99-114777

Published: 2018

Journal Articles

Rituximab Combined with Donor Lymphocyte Infusion Cured Immunohemolysis after Refractory Hematopoietic Stem Cell Transplantation

Jianyun Liao, MD, Zhiyong Peng, MD, Huaying Liu, MD, Yuelin He, MD, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 5745.

https://doi.org/10.1182/blood-2018-99-120163

Published: 2018

Journal Articles

Hypomethylation of Decitabine Improved Outcomes of Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia

Zhiyong Peng, MD, Xiaoqin Feng, PhD, Yuelin He, Yuchen Lin, Jianyun Liao, Xuedong Wu, MD, Jiaqi Chen, MD, Chunfu Li, MD

Blood (2017) 130 (Supplement 1): 3232.

https://doi.org/10.1182/blood.V130.Suppl_1.3232.3232

Published: 2017

NARROW

Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia

A Busulfan Following Cyclophosphamide and Constant Cell Dose Protocol Improved Results in Alternative Donor Hematologic Stem Cell Transplantation in Thalassemia Major: A Result from Long-Term Large-Size Multi-Center Study

Manufacturing Scale-up and Preclinical Development of ET-01, Autologous CD34 + Cells with the BCL11A Erythroid Enhancer Edited By CRISPR/Cas9, for Patients with β-Thalassemia Major

Complementary Transplantation with Unrelated Cord Blood Following Haploidentical Stem Cells for Juvenile Myelomonocytic Leukemia:Double-Centers Study from China

Improvement of Survival in JMML By Induction Regimen of Decitabine + Cytarabine + Fludarabine before Hematopoietic Stem Cell Transplantation: Study of 33 Cases in Single Center

Complementary Transplantation Improved Results of Both Peripheral Blood Stem Cells and Unrelated Cord Blood Transplants in Thalassemia: A Multi-Center Study from China

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

A Retrospective Analysis of Transplantation Related Mortality in 515 Cases of Children β-Thalassemia Major

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Rituximab Combined with Donor Lymphocyte Infusion Cured Immunohemolysis after Refractory Hematopoietic Stem Cell Transplantation

Hypomethylation of Decitabine Improved Outcomes of Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only